Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

BMC Cancer. 2023 Feb 27;23(1):192. doi: 10.1186/s12885-023-10662-3.
No abstract available

Publication types

  • Published Erratum